🌍

•1 hours ago

Guggenheim initiates Cullinan Oncology stock with Buy rating, $30 target

investing.com

Monday, February 2, 2026

1 min read

Guggenheim initiates Cullinan Oncology stock with Buy rating, $30 target

Share:

This article has no content available.

Read the full article

Continue reading on investing.com

More from investing.com

2 hours ago

Далай-лама получил "Грэмми" за лучшее озвучивание аудиокниги

2 hours ago

Gold, silver prices continue to fall. Should you buy now?

2 hours ago

Банки заявили о росте спроса на ипотеку в январе

2 hours ago

Accused triple murderer still on the run after almost two weeks